Mylan Loses Bid To Toss Daiichi Benicar Patent
By Melissa Lipman · September 10, 2010, 1:50 PM EDT
A federal appeals court has upheld an injunction banning Mylan Pharmaceuticals Inc. from making generic versions of Daiichi Sankyo Co. Ltd.'s Benicar and Azor until a patent for the hypertension drugs...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login